Flora Growth Corp. (NASDAQ:FLGC - Get Free Report) CEO Clifford Starke acquired 526,315 shares of the company's stock in a transaction dated Monday, April 8th. The stock was acquired at an average cost of $1.90 per share, with a total value of $999,998.50. Following the transaction, the chief executive officer now directly owns 565,714 shares of the company's stock, valued at $1,074,856.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Flora Growth Price Performance
FLGC opened at $2.17 on Wednesday. The company has a fifty day simple moving average of $1.33 and a 200 day simple moving average of $1.21. The firm has a market cap of $19.49 million, a price-to-earnings ratio of -0.22 and a beta of 1.91. Flora Growth Corp. has a twelve month low of $0.63 and a twelve month high of $5.48. The company has a current ratio of 1.31, a quick ratio of 0.79 and a debt-to-equity ratio of 0.15.
Institutional Investors Weigh In On Flora Growth
A number of large investors have recently added to or reduced their stakes in the company. Armistice Capital LLC acquired a new stake in Flora Growth during the 4th quarter valued at $949,000. Mirae Asset Global Investments Co. Ltd. boosted its stake in Flora Growth by 66.2% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 988,368 shares of the company's stock valued at $1,334,000 after acquiring an additional 393,780 shares during the last quarter. Renaissance Technologies LLC boosted its stake in Flora Growth by 1,037.0% during the 2nd quarter. Renaissance Technologies LLC now owns 623,073 shares of the company's stock valued at $380,000 after acquiring an additional 568,273 shares during the last quarter. Millennium Management LLC bought a new position in Flora Growth during the 2nd quarter valued at $260,000. Finally, Citadel Advisors LLC bought a new position in Flora Growth during the 2nd quarter valued at $212,000. 36.01% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Protect Your Bank Account Before It’s Too Late
From Weiss Ratings | Ad
For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account.
It gives them the power to monitor every single transaction …
Stop right now and do these 3 things to protect yourself
Separately, Roth Mkm raised their price target on shares of Flora Growth to $7.00 and gave the company a "buy" rating in a report on Wednesday, April 3rd.
View Our Latest Analysis on Flora Growth
About Flora Growth
(
Get Free Report)
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
